ArticleCancer science2023

Phase I trial of myeloablative conditioning with 3-day total marrow and lymphoid irradiation for leukemia.

Hiroaki Ogawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.